Cancer Clinical Trials
Leaders in Cancer Research
John Theurer Cancer Center is leading the way to a cancer cure through groundbreaking clinical research.
We believe all cancer patients deserve the latest innovative approaches to cancer treatment. That’s why our care teams screen all patients to see if you’re a match for a clinical trial. This gives you unparalleled access to treatments through clinical trials you won’t find anywhere else.
Largest Clinical Trials Program in New Jersey
John Theurer Cancer Center conducts more clinical trials than any other cancer center in New Jersey. Our patients have access to hundreds of clinical trials at every stage of development across every specialty of cancer.
Through our partnership with Lombardi Comprehensive Cancer Center at Georgetown University, John Theurer Cancer Center is a member of one of only 13 National Cancer Institute (NCI)-designated cancer consortia. We are two strong institutions that share a passion and expertise for developing therapies and delivery systems to improve cancer outcomes.
Together, we accelerate research to bring new cancer treatments from the laboratory to the bedside faster than ever.
Collaborating on Cures
Our unmatched experience and capabilities in cancer research position us as a preferred partner for drug development with large pharmaceutical companies headquartered right here in New Jersey and beyond.
Through these unique collaborations, our researchers have already played a critical role in bringing to market many of the prominent anticancer drugs used today.
Pioneering Personalized, Highly Targeted Treatments
At John Theurer Cancer Center, our precision medicine approach to treating cancer begins with genetic testing. Most cancer biopsies undergo detailed DNA analysis to create a molecular profile. Whenever possible, we match you with a clinical trial of the latest treatment approach designed to more effectively kill your exact type of cancer with fewer side effects.
Our researchers are on the front lines developing game-changing, highly targeted cancer treatments including:
- CAR T-cell therapies
- Immune checkpoint inhibitors
- Monoclonal antibodies
- Treatment vaccines
- Immune system modulators
Phase 1 Clinical Trials
At John Theurer Cancer Center, you benefit from one of the nation’s leading phase 1 clinical research programs. Representing nearly one third of our cancer research, phase 1 clinical trials allow our patients to receive exciting and innovative cancer therapies before anyone else.
If you’ve been told there are no treatment options for your type of cancer, or your cancer has not responded to standard treatment, contact us at 551-996-1777 to see if a phase I study at John Theurer Cancer Center could be an option for you.
Commitment to Diverse Populations
We’re committed to making our clinical trials available to all cancer patients, regardless of race and ethnicity. This commitment to diversity and inclusion, along with our broad reach of locations across New Jersey, means more people have access to more clinical trials of groundbreaking cancer treatment close to home.
John Theurer Cancer Center has recruited cancer doctors from around the world to provide you with award-winning cancer treatment and care. It’s easy to get started with your cancer care. Call 833-CANCER-MD today. We will schedule your appointment promptly.
Why Choose Hackensack Meridian Health
John Theurer Cancer Center’s breast cancer hospital program received the Gold Seal of Approval™ and Disease-Specific Care Certification from The Joint Commission and accreditation from the National Accreditation Program for Breast Centers by the American College of Surgeons.
Our team uses genetic-based precision medicine to select the treatments and therapies best suited for your specific type of breast cancer. We also use state-of-the-art technology to better define how and when to use chemotherapy appropriately and safely.
Many of our breast cancer treatment centers use an innovative scalp cooling system that helps prevent or reduce hair loss in patients who are receiving chemotherapy for breast cancer.